Skip to main content
JUSHF
OTC Life Sciences

Jushi Holdings Proposes Redomicile to Nevada for Strategic Alignment and Efficiency

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.5
Mkt Cap
$99.848M
52W Low
$0.265
52W High
$0.98
52W Position info
89% above low
Off High info
49% below high
Rel. Volume info
6.4× avg
Market data snapshot near publication time

JUSHF sits 89% above its 52-week low of $0.265 on elevated volume (6.4× avg).

Summary

Jushi Holdings Inc. announced a proposed redomicile from British Columbia, Canada, to Nevada, USA, to align its corporate structure with its U.S. operations and enhance efficiency.


Key Events · Corporate Governance and Compliance · JUSHF

  • Proposed Redomicile to Nevada

    Jushi Holdings Inc. is proposing to change its legal domicile from British Columbia, Canada, to the U.S. state of Nevada.

  • Strategic Alignment and Efficiency

    The move is intended to better align the company's corporate structure with its U.S.-focused operations and long-term strategy, aiming for streamlined organization and improved efficiency.

  • Shareholder Approval Required

    The proposed redomicile requires approval from 66 2/3% of votes cast by shareholders at an upcoming annual general and special meeting.

  • No Material Operational Change Expected

    The company states that the arrangement, including the continuance, is not expected to cause any material change in its business or operations.


Analysis · JUSHF · Life Sciences

Jushi Holdings Inc. is seeking shareholder approval to redomicile its legal entity from British Columbia, Canada, to Nevada, United States. This strategic move aims to better align the company's corporate structure with its U.S.-focused cannabis operations and long-term strategy, potentially streamlining the organization and improving efficiency. While the change requires a 66 2/3% shareholder vote, it is not expected to materially alter the company's business or operations. This redomicile could enhance Jushi's appeal to U.S. investors and simplify its regulatory framework, marking a significant step in its corporate evolution.

At the time of this filing, JUSHF was trading at $0.50 on OTC in the Life Sciences sector, with a market capitalization of approximately $99.8M. The 52-week trading range was $0.27 to $0.98. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

JUSHF - Latest Insights

JUSHF
Jul 28, 2026, 4:36 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.3858
Real-time Price: $0.3859 info
Change: +$0.0001 (+0.03%) info
Market Cap: $77.063M info
JUSHF
Jul 28, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.3858
Real-time Price: $0.3859 info
Change: +$0.0001 (+0.03%) info
Market Cap: $77.063M info
JUSHF
Jun 24, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4401
Real-time Price: $0.3859 info
Change: -$0.0542 (-12%) info
Market Cap: $77.063M info
JUSHF
May 12, 2026, 4:26 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.500
Real-time Price: $0.3859 info
Change: -$0.1141 (-23%) info
Market Cap: $77.063M info
JUSHF
May 12, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.500
Real-time Price: $0.3859 info
Change: -$0.1141 (-23%) info
Market Cap: $77.063M info